AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Quaedvlieg, PFHJ Visser, O Lamers, CBHW Janssen-Heijen, MLG Taal, BG
Citation: Pfhj. Quaedvlieg et al., Epidemiology and survival in patients with carcinoid disease in the Netherlands - An epidemiological study with 2391 patients, ANN ONCOL, 12(9), 2001, pp. 1295-1300

Authors: Vasen, HFA Stormorken, A Menko, FH Nagengast, FM Kleibeuker, JH Griffioen, G Taal, BG Moller, P Wijnen, JT
Citation: Hfa. Vasen et al., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families, J CL ONCOL, 19(20), 2001, pp. 4074-4080

Authors: Westermann, AM Taal, BG Swart, M Boot, H Craanen, M Gerritsen, WR
Citation: Am. Westermann et al., Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: A feasibility study, PHARMAC RES, 42(2), 2000, pp. 151-156

Authors: Taal, BG Hoefnagel, C Boot, H Olmos, RV Rutgers, M
Citation: Bg. Taal et al., Improved effect of I-131-MIBG treatment by predosing with non-radiolabeledMIBG in carcinoid patients, and studies in xenografted mice, ANN ONCOL, 11(11), 2000, pp. 1437-1443

Authors: Hoefnagel, CA Taal, BG Sivro, F Boot, H Olmos, RAV
Citation: Ca. Hoefnagel et al., Enhancement of I-131-MIBG uptake in carcinoid tumours by administration ofunlabelled MIBG, NUCL MED C, 21(8), 2000, pp. 755-761

Authors: Van Triest, B Loftus, BM Pinedo, HM Backus, HHJ Schoenmakers, P Telleman, F Tadema, T Aherne, GW Van Groeningen, CJ Zoetmulder, FAN Taal, BG Johnston, PG Peters, GJ
Citation: B. Van Triest et al., Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody, J HIST CYTO, 48(6), 2000, pp. 755-760

Authors: Taal, BG Peterse, H Boot, H
Citation: Bg. Taal et al., Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma, CANCER, 89(11), 2000, pp. 2214-2221

Authors: Sparidans, RW Taal, BG Beijnen, JH
Citation: Rw. Sparidans et al., Bioanalysis of m-iodobenzylguanidine in plasma by high-performance liquid chromatography after derivatization with benzoin, J CHROMAT B, 730(2), 1999, pp. 193-199

Authors: Zuetenhorst, H Taal, BG Boot, H Olmos, RV Hoefnagel, G
Citation: H. Zuetenhorst et al., Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBC): pharmacological MIBG, I-131-labelled MIBG and the combination, EUR J GASTR, 11(10), 1999, pp. 1157-1164

Authors: de Jong, D Aleman, BMP Taal, BG Boot, H
Citation: D. De Jong et al., Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey, ANN ONCOL, 10(3), 1999, pp. 275-280

Authors: Taal, BG Hoefnagel, C Rutgers, M
Citation: Bg. Taal et al., Carcinoid tumors, N ENG J MED, 341(6), 1999, pp. 454-454

Authors: Taal, BG Westerman, H Boot, H Rankin, EM
Citation: Bg. Taal et al., Clinical and endoscopic features of melanoma metastases in the upper GI tract, GASTROIN EN, 50(2), 1999, pp. 261-263
Risultati: 1-12 |